Navigation Links
Codexis Presents Carbon Capture Update at DoE/NETL Conference
Date:8/24/2011

said "could fundamentally change the way the country uses and produces energy."  

Codexis is a clean technology company. Codexis develops optimized biocatalysts that make industrial processes faster, cleaner and more efficient. Codexis' technology is commercialized with leading global pharmaceutical companies and is in development for advanced biofuels with Shell, carbon capture and biobased chemicals.  Wastewater treatment is a potential future market. For more information, visit www.codexis.com.

This press release contains forward-looking statements relating to Codexis' research in carbon capture technology and the ability of our carbon capture technology to substantially reduce the costs and energy requirements to capture CO2 produced by coal-fired power plants.  You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control and that could materially affect actual results. Factors that could materially affect actual results can be found in Codexis' Quarterly Report on Form 10-Q dated August 3, 2011 including under the caption "Risk Factors." Codexis expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.

Media: Lyn Christenson, lyn.christenson@codexis.com, 650.421.8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212.827.3771 Investors:  Henk Adriaenssens, ir@codexis.com, 650.421.8331


'/>"/>
SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Codexis Board Elects Pedro I. Mizutani, Raizen EVP, as Director
2. Codexis Reports Second Quarter 2011 Results
3. Codexis and Chemtex to Collaborate on Sustainable Detergent Alcohols for the Household Products Market
4. Codexis to Present at the Pacific Crest and Canaccord Genuity Conferences
5. Codexis to Present at 3 Investor Conferences in June
6. Codexis Achieves Development Milestones With Teva
7. Codexis to Present at Barclays Conference
8. Codexis to Announce First Quarter 2011 Financial Results on May 5, 2011
9. Codexis Names Jacques Beaudry-Losique VP Corporate Development & Strategy
10. Codexis Announces Carbon Capture Progress at ARPA-E Summit
11. Codexis Names David Anton CTO & SVP, Process Development & Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 22, 2013 Attorney Advertising -- Bronstein, Gewirtz ... behalf of purchasers of the securities of AMAG ... -News).  The investigation focuses on whether the Company ... On May 22, 2013, Shares of AMAG ... the company announced in regulatory filing that it ...
(Date:5/22/2013)... and MUNICH , May 22, 2013 /PRNewswire/ ... marketer of transcatheter aortic valve implantation (TAVI) systems for the ... results of the J enaValve Eval U ation of ... Pa T ients with S E vere Ao R tic ... . JUPITER is a post-market registry to evaluate five-year long ...
(Date:5/22/2013)... 22, 2013 The new 13-valent pneumococcal conjugate ... previous version used prior to 2010, the 7-valent pneumococcal ... published today in Vaccine. The U.S. Food ... 2010 after a series of trials. These trials found ... pneumococcal types than the previously used PCV7, did not ...
Breaking Medicine Technology:Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4
... for New Combination, PARSIPPANY, N.J., May 21, ... amlodipine besylate with the angiotensin,receptor blocker olmesartan ... and diastolic blood pressure in,patients with hypertension, ... of Hypertension's Twenty-Second Annual Scientific,Meeting and Exposition ...
... Company (NYSE: BMY) today announced new data ... Baraclude (entecavir),demonstrated greater viral load reduction than ... was also seen at weeks 12 (primary ... randomized viral kinetics study,of 69 antiviral-naive chronic ...
Cached Medicine Technology:Amlodipine and Olmesartan Study Results Released; Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 2Amlodipine and Olmesartan Study Results Released; Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 3Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 2Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 3Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 4Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 5Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 6
(Date:5/23/2013)... Following the recent outbreak of fake Amazon emails ... team at idcloak Technologies has identified a new form ... web-born malware. Gill-Chris Welles of the idcloak security ... privacy and security than traditional antivirus software. ... AV software cannot be depended on: it takes a ...
(Date:5/23/2013)... 2013 When Teachers Notebook reached out ... raise funds for the Moore, OK tornado victims, they ... items that could be sold for around $10.00 with ... at Teachers Notebook were overwhelmed by the response from ... of materials within the first 12 hours of the ...
(Date:5/23/2013)... GBI Research’s analysis indicates that the global critical care ... of players accounting for a major proportion of the overall ... between 2006 and 2012, possibly due to the lack of ... in the US. , GBI Research estimates that the ... 2012, having grown in size at a CAGR of 11% ...
(Date:5/22/2013)... The surging growth in specialty beds ... marketing claims to compare mattresses often proves a bit ... bed blog , offers shoppers faced with this dilemma ... latest article. , Titled “ Mattress Comparison Overview – ... readers through the basics of innerspring beds as well ...
(Date:5/22/2013)... On May 16, 2012, LifeHealthPro reported ... funeral concierge can help families negotiate lower costs for all ... Financials announces their top 3 reasons to hire a ... the U.S. having dropped 7.3 percent from $55,438 to $51,404 ... costs 12.6% of an average U.S. households annual income. , ...
Breaking Medicine News(10 mins):Health News:Effective virus protection without anti-virus software, identifies idcloak 2Health News:Teachers Rally to Raise Funds for Moore Tornado Victims 2Health News:MarketResearch.com Report – Increased Cost of Albumin was Main Factor for Double-Digit Growth of Global Critical Care Market Between 2006 and 2012 2Health News:Mattress Comparison Overview Released by The Sleepy Shopper; Compares Top Types and Brands 2Health News:Funeral Financials Announces Their Top 3 Reasons to Hire a Funeral Concierge 2Health News:Funeral Financials Announces Their Top 3 Reasons to Hire a Funeral Concierge 3
... Stanford University School of Medicine,s Todd Ferris, Associate ... Information Privacy and Security; and Robert ... WHAT: "Improving Network Security and Management", WHEN: 11:45 ... Western Regional Conference 2008 InterContinental ...
... in a cup, instead of bracing for a needle prick, ... major step in that direction is the cataloguing of the ... saliva, identified by a consortium of three research teams, according ... Research. Replacing blood draws with saliva tests promises to make ...
... 25 Laerdal Medical,Corporation announces a strategic ... Supply Chain Systems has awarded Laerdal,a multi-year ... The,contract is effective January 1 through December ... ), Bruce Cadwell, Laerdal,s National Accounts ...
... Fit and Fabulous ... to Lower Breast Cancer Risk, DALLAS, March 25 ... Cure(R),s Circle of Promise campaign has,teamed with Dr. Rovenia ("Dr. Ro") ... living to,help lower their risk of breast cancer. In the coming ...
... Skin Cancer with State-of-the-Art Technology, EAST RUTHERFORD, ... one of the nation,s top 10 public relations ... client roster. Developed in New,Zealand, MoleSafe is a ... of moles and other suspicious lesions to,help detect ...
... 25 Ochsner Health System of New,Orleans ... throughout their,perioperative (surgical) process with technology from ... (AIMS), medication,management system and presurgical care management ... implementation of DocuSys, Ochsner will,strategically focus on ...
Cached Medicine News:Health News:Stanford University School of Medicine to Address 'Improving Network Security and Management' at EDUCAUSE Western Regional Conference 2008 Using Lancope's StealthWatch System for Network Behavior Analysis 2Health News:Spit tests may soon replace many blood tests 2Health News:Spit tests may soon replace many blood tests 3Health News:Laerdal Medical Announces Strategic Relationship 2Health News:Dr. Rovenia Brock Brings Secrets of Living Healthy to Susan G. Komen for the Cure(R)'s Circle of Promise 2Health News:Dr. Rovenia Brock Brings Secrets of Living Healthy to Susan G. Komen for the Cure(R)'s Circle of Promise 3Health News:MWW Group Retained by MoleSafe 2Health News:Ochsner Health System Partners with DocuSys for Presurgical Care, AIMS and Medication Management Technology 2Health News:Ochsner Health System Partners with DocuSys for Presurgical Care, AIMS and Medication Management Technology 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: